Acute therapy with hemopexin (CSL889) resolves LPS-induced lung vaso-occlusion in sickle mice

Blood Vessels Thrombosis & Hemostasis · Published 2026-07-13 · DOI 10.1016/j.bvth.2026.100189

Free full text

Authors (13)

Rikesh K. Dubey, Ravi Vats, Thomas Gentinetta, Tomasz W. Kaminski, Manikanta, Omika Katoch, Tirthadipa Pradhan-Sundd, Jesus Tejero, Brandon Greene, Gregory J. Kato, Paolo Rossato, Gerald Hoebarth, Prithu Sundd

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Dubey, R., Vats, R., Gentinetta, T., et al. (2026). Acute therapy with hemopexin (CSL889) resolves LPS-induced lung vaso-occlusion in sickle mice. Blood Vessels Thrombosis & Hemostasis. https://doi.org/10.1016/j.bvth.2026.100189

Related articles

• Abnormal whole-blood viscoelastic test results in patients with bleeding disorder of unknown cause · Blood Vessels Thrombosis & Hemostasis · 2026 · Same journal
• Doxycycline for Epistaxis in Hereditary Hemorrhagic Telangiectasia: Genotype-Stratified Outcomes · Blood Vessels Thrombosis & Hemostasis · 2026 · Same journal
• Sirolimus Outperforms Alpelisib in Models of NRASQ61R-Driven Vascular Overgrowth · Blood Vessels Thrombosis & Hemostasis · 2026 · Same journal
• Tryptophan metabolism reprogramming potentially contributes to the prothrombotic milieu in mice and humans with SARS-CoV-2 · Blood Vessels Thrombosis & Hemostasis · 2026 · Same journal
• NETs contribute to acute episodes but not ADAMTS13 relapses in immune-mediated thrombotic thrombocytopenic purpura · Blood Vessels Thrombosis & Hemostasis · 2026 · Same journal
• VLX-1005, but not argatroban, prevents ITAM-mediated platelet activation and heparin-induced thrombocytopenia · Blood Vessels Thrombosis & Hemostasis · 2026 · Same journal
• Successful eltrombopag discontinuation in paraneoplastic immune thrombocytopenia: a case report · Blood Vessels Thrombosis & Hemostasis · 2026 · Same journal
• Alpelisib, a PI3Kα inhibitor, effectively treats vascular anomalies with diverse genotypes and phenotypes · Blood Vessels Thrombosis & Hemostasis · 2025 · Same journal
• Safety and real-world effectiveness of eptacog beta with emicizumab prophylaxis: an interim analysis of the ATHN 16 study · Blood Vessels Thrombosis & Hemostasis · 2026 · Same journal
• Interactions of dual antiplatelet and anticoagulant with C1q and FH regulate complement activation by injured cells · Blood Vessels Thrombosis & Hemostasis · 2026 · Same journal